Viemed Healthcare, Inc.
Viemed Healthcare, Inc. (VMD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
vmd · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Viemed Healthcare, Inc. (VMD) measures how much investors pay for each dollar of the company's trailing earnings. VMD's current PE ratio of 25.60x is calculated by dividing its stock price of $9.92 by its TTM earnings per share of $0.39. −12.3% discount vs 5Y avg 29.2x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2014 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 12 fiscal years · Front-end computedMinQ1 · 25%21.0x
MedianQ3 · 75%55.4x
Max
At 25.60x, VMD's current P/E is within its average historical range over the past 12 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Viemed Healthcare, Inc.You VMD | $380M | 25.60x | — | $0.39 |
 CVRx, Inc. CVRX | $143M | N/A | — | -$2.04 |
 Electromed, Inc. ELMD | $307M | 24.32x | — | $0.90 |
 Inogen, Inc. INGN | $164M | N/A | — | -$0.84 |
 908 Devices Inc. MASS | $306M | N/A | — | -$1.01 |
 Nano-X Imaging Ltd. NNOX | $127M | N/A | — | -$1.16 |
 Outset Medical, Inc. OM | $80M | N/A | — | -$5.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 19.35x | $0.38 | -29.9% | |
2024-12-31 FY2024 | 27.59x | $0.29 | -6.1% | |
2023-12-31 FY2023 | 29.39x | $0.27 | -37.4% | |
2022-12-31 FY2022 | 46.97x | $0.16 | +107.9% | |
2021-12-31 FY2021 | 22.59x | $0.23 | +136.9% | |
2020-12-31 FY2020 | 9.54x | $0.81 | -65.2% | |
2019-12-31 FY2019 | 27.43x | $0.23 | +93.9% | |
2018-12-31 FY2018 | 14.15x | $0.27 | +70.1% | |
2017-12-31 FY2017 | 8.32x | $0.22 | -85.0% | |
2016-12-31 FY2016 | 55.37x | $0.03 | +4493.3% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Viemed Healthcare, Inc. (VMD) measures how much investors pay for each dollar of the company's trailing earnings. VMD's current PE ratio of 25.60x is calculated by dividing its stock price of $9.92 by its TTM earnings per share of $0.39.
Frequently asked questions
VMD pe ratio · 6 questionsVMD's current PE ratio is 25.60x as of 2026-06-09, based on a stock price of $9.92 and TTM EPS of $0.39. Data sourced from Financial Modeling Prep via VMD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Viemed Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09